Drug Formulary Review Archives – September 1, 2001
September 1, 2001
View Issues
-
Privacy rule guidance clarifies medication consent question
-
Patient safety standards: An opportunity to shine
-
ASHP begins ‘medication safety officer’ initiative
-
Guest column - Tikosyn: A new Class III antiarrhythmic
-
News briefs: Baycol withdrawn; Alzheimer's vaccine promising; FDA nixes diabetes drug; Lamictal label changes; small drug updates
-
In the Pipeline
-
Drug Criteria & Outcomes: Formulary evaluation of sedative/hypnotic agents
-
Drug Criteria & Outcomes: New FDA Approvals
-
Drug Criteria & Outcomes: Hepatitis primer: A, B, C